Revues phares et communiqués de presse
-
In this interview we asked authors Dr Laurence Le Cleach and Emilie Sbidian to tell us more about this Cochrane Living Systematic Review: Systemic pharmacological treatments for chronic plaque psoriasis, network meta analysisTell us about this Cochrane Review...Psoriasis is a frequent inflammatory skin disease affecting between 2 and 8% of the...9 janvier 2020 -
There are more than 50 Cochrane Reviews of the effects of interventions to help people quit smoking; one of which investigates whether reducing smoking before quitting might be an alternative to stopping suddenly. It was updated in September 2019 and we asked lead author, Nicola Lindson, from the Cochrane Tobacco Addiction Group based in the...6 janvier 2020 -
In this interview with review author Anjna Rani we learn more about the recently published review, Interventions to reduce Staphylococcus aureus in the management of eczema.Tell us about this Cochrane Review This review looks at the evidence of treatments, such as antibiotics, antibacterial soaps/baths, to reduce a type of bacteria called...16 décembre 2019 -
Multiple myeloma is a type of blood cancer. It accounts for approximately 2% of all cancers and is still considered incurable. For people with newly diagnosed multiple myeloma (NDMM), who are unsuitable for a procedure where damaged blood cells are replaced with healthy ones (stem-cell transplant), treatment is usually a multiple drug combination...26 November 2019 -
New evidence published in the Cochrane Library today provides further information on the benefits and harms of different human papillomavirus (HPV) vaccines and vaccine schedules in young women and men.HPV is the most common viral infection of the reproductive tract in both women and men globally (WHO 2017). Most people who have sexual contact...22 November 2019 -
New Cochrane Library Special Collection 20 November 2019 is the Global Initiative for Chronic Obstructive Pulmonary Disease’s World COPD day. Chronic obstructive pulmonary disease (COPD) is a chronic lung disease. The main symptoms are shortness of breath, cough, and sputum production. COPD is caused by breathing in noxious particles or gases from...19 November 2019 -
Interview with review author Beverley Lim Høeg, from the Danish Cancer Society Research CenterWhat is the aim of this review?More and more people are surviving cancer and receiving follow-up care. The aim of this review was to compare the effectiveness of different types of follow-up care after completion of cancer treatment on the outcomes of...12 November 2019 -
Rebecca Selby, a mum of four, shares how a Cochrane Review impacted her family.When I unexpectedly went into premature labour with our second son at a little under 32 weeks' gestation, I was given steroid injections to give his lungs the best possible chance in the outside world. George spent almost a month in intensive care when he was born,...1 November 2019 -
Most Cochrane Reviews look at the effects of interventions on health, but a growing number provide evidence on how to diagnose a disease. In June 2019, one of these, on a test used to detect tuberculosis, was updated. The lead author, David Horne from the University of Washington in Seattle in the USA, sets the scene and tells us what the review...28 octobre 2019 -
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The...21 octobre 2019
Pages
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- suivante ›
- dernière »
Les traductions sur ce site ont été rendues possibles grâce à la contribution financière du Ministère français des affaires sociales et de la santé et des instituts publics de recherche canadiens.